Joint Department of Medical Imaging, University Health Network, Mt. Sinai & WCH, University of Toronto, 585 University Ave., Toronto, ON, M5G 2N2, Canada.
St. Michael's Hospital, University of Toronto, 30 Bond St., Toronto, Ontario, M5B 1W8, Canada.
Eur Radiol. 2020 Jul;30(7):3735-3747. doi: 10.1007/s00330-020-06728-6. Epub 2020 Mar 4.
To compare biliary stricture severity on magnetic resonance cholangiopancreatography (MRCP), magnetic resonance elastography (MRE), and vibration-controlled transient elastography (VCTE) liver stiffness (LS) for evaluation of risk stratification and prognostication in primary sclerosing cholangitis (PSC).
Eighty-seven patients (31-61 years; 34 female/53 male) prospectively underwent biochemical testing, VCTE, MRCP, and MRE between January 2014 and July 2016. Correlation between the MRCP grading of PSC based on biliary stricture severity, LS on MRE and VCTE, and the Mayo Risk Score as well as the Amsterdam Oxford Prognostic Index (AOPI) were evaluated and compared. Stricture severity was classified according to previous classification systems based on ERCP. Spearman's correlation and Kruskal-Wallis tests were performed.
MRE-LS and intrahepatic stricture severity combined demonstrated higher discriminatory ability among risk categories based on Mayo Risk Score (AUROC = 0.8). MRE-LS alone demonstrated excellent discriminatory ability among risk categories based on AOPI using cutoffs of 1 and 2.7 and was superior to intrahepatic stricture severity (AUROC = 0.9, AUROC = 0.6-0.7). There was a weak correlation between intrahepatic stricture severity and MRE-LS (rho = 0.3; p = 0.011). VCTE-LS values were not correlated with stricture severity and were noncontributory to differentiate patients across risk groups. Intrahepatic stricture severity alone was a poor discriminator of advanced liver fibrosis on MRE (AUROC = 0.7); however, combining intra- and extrahepatic stricture severity and controlling for cholestasis and disease duration improved results (AUROC = 0.9).
This study demonstrates a significant discriminatory ability of LS values on MRE to distinguish between early to moderate and advanced liver fibrosis. LS values on MRE may add value to risk prognostication and further studies including clinical outcomes are needed.
• Risk stratification was excellent for liver stiffness measurements on MRE and poor for VCTE and biliary stricture severity. • Risk stratification was further improved when liver stiffness measured on MRE was combined with intrahepatic and extrahepatic stricture severity and indicators of cholestasis were controlled for. • Liver stiffness measurements on MRE correlated with prognostic scores better than measurements performed on VCTE.
比较磁共振胰胆管成像(MRCP)、磁共振弹性成像(MRE)和振动控制瞬态弹性成像(VCTE)肝硬度(LS)在原发性硬化性胆管炎(PSC)中的评估风险分层和预后的胆管狭窄严重程度。
87 例患者(31-61 岁;34 名女性/53 名男性)于 2014 年 1 月至 2016 年 7 月前瞻性接受生化检测、VCTE、MRCP 和 MRE。评估和比较了基于胆管狭窄严重程度的 MRCP 分级、MRE 和 VCTE 的 LS 与 Mayo 风险评分以及阿姆斯特丹牛津预后指数(AOPI)之间的相关性。根据之前基于 ERCP 的分类系统对狭窄严重程度进行分类。进行了 Spearman 相关和 Kruskal-Wallis 检验。
MRE-LS 和肝内狭窄严重程度联合显示基于 Mayo 风险评分的风险类别之间具有更高的区分能力(AUROC=0.8)。MRE-LS 单独用于基于 AOPI 的风险类别具有出色的区分能力,截断值为 1 和 2.7,优于肝内狭窄严重程度(AUROC=0.9,AUROC=0.6-0.7)。肝内狭窄严重程度与 MRE-LS 之间存在弱相关性(rho=0.3;p=0.011)。VCTE-LS 值与狭窄严重程度无关,对区分风险组中的患者没有帮助。单独的肝内狭窄严重程度是 MRE 上晚期肝纤维化的不良鉴别器(AUROC=0.7);然而,联合肝内和肝外狭窄严重程度并控制胆汁淤积和疾病持续时间可改善结果(AUROC=0.9)。
本研究表明,MRE 上 LS 值对区分早期至中度和晚期肝纤维化具有显著的区分能力。MRE 上的 LS 值可能对风险预测具有附加值,需要进一步研究包括临床结果。
• MRE 上的风险分层对 LS 测量具有出色的效果,而对 VCTE 和胆管狭窄严重程度的效果较差。
• 当 MRE 上的 LS 测量值与肝内和肝外狭窄严重程度以及胆汁淤积的指标相结合并加以控制时,风险分层得到进一步改善。
• MRE 上的 LS 测量值与预后评分的相关性优于 VCTE 上的测量值。